lOMoARcPSD| 13728229
lOMoARcPSD| 13728229
, lOMoARcPSD| 13728229
Chapter .01: .Nursing .Practice .in .Canada .and .Drug .Therapy
Sealock: .Lilley’s .Pharmacology .for .Canadian .Health .Care .Practice, .4th .Edition
MULTIPLE .CHOICE
1. Which .is .a .judgement .about .a .particular .patient‘s .potential .need .or .problem?
a. A .goal
b. An .assessment
c. Subjective .data
d. A .nursing .diagnosis
ANS: . D
Nursing .diagnosis .is .the .phase .of .the .nursing .process .during .which .a .clinical .judgement .is .made .abo
.to .heath .conditions .and .life .processes .or .vulnerability .for .that .response.
DIF: Cognitive .Level: .Knowledge
2. The .patient .is .to .receive .oral .furosemide .(Lasix) .every .day; .however, .because .the .patient .is .unable .t
.take .medication .orally, .as .ordered. .The .nurse .needs .to .contact .the .physician. .What .type .of .problem
a. A .―right .time‖ .problem
b. A .―right .dose‖ .problem
c. A .―right .route‖ .problem
d. A .―right .medication‖ .problem
ANS: . C
This .is .a .―right .route‖ .problem: .the .nurse .cannot .assume .the .route .and .must .clarify .the .route .with
.―right .time‖ .problem .because .the .ordered .frequency .has .not .changed. .This .is .not .a .―right .dose‖ .p
.not .related .to .an .inability .to .swallow. .This .is .not .a .―right .medication‖ .problem .because .the .m
.change, .just .the .route.
DIF: Cognitive .Level: .Application
3. The .nurse .has .been .monitoring .the .patient‘s .progress .on .his .new .drug .regimen .since .the .first .dose .an
.signs .of .possible .adverse .effects. .What .nursing .process .phase .is .the .nurse .practising?
a. Planning
b. Evaluation
c. Implementation
d. Nursing .diagnosis
ANS: . B
Monitoring .the .patient‘s .progress .is .part .of .the .evaluation .phase. .Planning, .implementation, .and .nurs
.illustrated .by .this .example.
DIF: Cognitive .Level: .Application
4. The .nurse .is .caring .for .a .patient .who .has .been .newly .diagnosed .with .type .1 .diabetes .mellitus. .Which
.illustrates .an .outcome .criterion .for .this .patient?
a. The .patient .will .follow .instructions.
b. The .patient .will .not .experience .complications.
c. The .patient .adheres .to .the .new .insulin .treatment .regimen.
d. The .patient .demonstrates .safe .insulin .self-administration .technique.
ANS: . D
Having .the .patient .demonstrate .safe .insulin .self-administration .technique .is .a .specific .and .measurabl
.Following .instructions .and .avoiding .complications .are .not .specific .criteria. .Adherence .to .the .new .in
.not .objective .and .would .be .difficult .to .measure.
DIF: Cognitive .Level: .Application
, lOMoARcPSD| 13728229
6. The .nurse .is .working .during .a .very .busy .night .shift, .and .the .health .care .provider .has .just .given .the .n
.over .the .telephone, .but .the .nurse .does .not .recall .the .route. .What .is .the .best .way .for .the .nurse .to .av
a. Recopy .the .order .neatly .on .the .order .sheet, .with .the .most .common .route .indicated
b. Consult .with .the .pharmacist .for .clarification .about .the .most .common .route
c. Call .the .health .care .provider .to .clarify .the .route .of .administration
d. Withhold .the .drug .until .the .health .care .provider .visits .the .patient
ANS: . C
If .a .medication .order .does .not .include .the .route, .the .nurse .must .ask .the .health .care .provider .to .clarif
.administration.
DIF: Cognitive .Level: .Application .| .Cognitive .Level: .Analysis
7. Which .constitutes .the .traditional .Five .Rights .of .medication .administration?
a. Right .drug, .right .route, .right .dose, .right .time, .and .right .patient
b. Right .drug, .the .right .effect, .the .right .route, .the .right .time, .and .the .right .patient
c. Right .patient, .right .strength, .right .diagnosis, .right .drug, .and .right .route
d. Right .patient, .right .diagnosis, .right .drug, .right .route, .and .right .time
ANS: . A
The .traditional .Five .Rights .of .medication .administration .were .considered .to .be .Right .drug, .Right .rou
.Right .patient. .Right .effect, .right .strength, .and .right .diagnosis .are .not .part .of .the .traditional .Five .Rig
DIF: Cognitive .Level: .Comprehension
8. What .correctly .describes .the .nursing .process?
a. Diagnosing, .planning, .assessing, .implementing, .and .finally .evaluating
b. Assessing, .then .diagnosing, .implementing, .and .ending .with .evaluating
c. A .linear .direction .that .begins .with .assessing .and .continues .through
.diagnosing, .planning, .and .finally .implementing
d. An .ongoing .process .that .begins .with .assessing .and .continues .with
.diagnosing, .planning, .implementing, .and .evaluating
ANS: . D
The .nursing .process .is .an .ongoing, .flexible, .adaptable, .and .adjustable .five-step .process .that .begins .w
.through .diagnosing, .planning, .implementing, .and .finally .evaluating, .which .may .then .lead .back .to .an
DIF: Cognitive .Level: .Application
9. When .the .nurse .is .considering .the .timing .of .a .drug .dose, .which .is .most .important .to .assess?
a. The .patient‘s .identification
b. The .patient‘s .weight
c. The .patient‘s .last .meal
d. Any .drug .or .food .allergies
ANS: . C
The .pharmacokinetic .and .pharmacodynamic .properties .of .the .drug .need .to .be .assessed .with .regard .to
.compatibility .issues. .The .patient‘s .identification, .weight, .and .drug .or .food .allergies .are .not .affected
DIF: Cognitive .Level: .Application
10. The .nurse .is .writing .nursing .diagnoses .for .a .plan .of .care. .Which .reflects .the .correct .format .for .her .n
a. Anxiety
b. Anxiety .related .to .new .drug .therapy
c. Anxiety .related .to .anxious .feelings .about .drug .therapy, .as .evidenced
.by .statements .such .as .―I‘m .upset .about .having .to .give .myself .shots‖
d. Anxiety .related .to .new .drug .therapy, .as .evidenced .by .statements .such .as
.―I‘m .upset .about .having .to .give .myself .shots‖
ANS: . D
Formulation .of .nursing .diagnoses .is .usually .a .three-step .process. .The .only .complete .answer .is .―Anx
, lOMoARcPSD| 13728229
Chapter .02: .Pharmacological .Principles
Sealock: .Lilley’s .Pharmacology .for .Canadian .Health .Care .Practice, .4th .Edition
MULTIPLE .CHOICE
1. A .patient .is .receiving .two .different .drugs, .which, .at .their .current .dose .forms .and .dosages, .are .both .a
.circulation .in .identical .amounts. .Which .term .best .denotes .that .the .drugs .have .the .same .absorption .r
a. Equivalent
b. Synergistic
c. Compatible
d. Bioequivalent
ANS: . D
Two .drugs .absorbed .into .the .circulation .at .the .same .amount .(in .specific .dosage .forms) .have .the .sam
.are .bioequivalent. .―Equivalent‖ .is .incorrect .because .the .term .―bioavailability‖ .is .used .to .express .the
.―Synergistic‖ .is .incorrect .because .this .term .refers .to .two .drugs .given .together .whose .resulting .effec
.the .effects .of .each .drug .given .alone. .―Compatible‖ .is .incorrect .because .this .term .is .a .general .term .u
.substances .do .not .have .a .chemical .reaction .when .mixed .(or .given, .in .the .case .of .drugs) .together.
DIF: Cognitive .Level: .Comprehension
2. A .patient .is .receiving .medication .via .intravenous .injection. .Which .information .should .the .nurse .prov
a. The .medication .will .cause .fewer .adverse .effects .when .given .intravenously.
b. The .medication .will .be .absorbed .slowly .into .the .tissues .over .time.
c. The .medication‘s .action .will .begin .faster .when .given .intravenously.
d. Most .of .the .drug .is .inactivated .by .the .liver .before .it .reaches .the .target .area.
ANS: . C
Intravenous .injections .are .the .fastest .route .of .absorption. .The .intravenous .route .does .not .affect .the .n
.the .intravenous .route .is .not .a .slow .route .of .absorption, .and .the .intravenous .route .does .not .cause .ina
.the .liver .before .it .reaches .the .target .area.
DIF: Cognitive .Level: .Comprehension
3. Which .is .true .regarding .parenteral .drugs?
a. They .bypass .the .first-pass .effect.
b. They .decrease .blood .flow .to .the .stomach.
c. They .are .altered .by .the .presence .of .food .in .the .stomach.
d. They .exert .their .effects .while .circulating .in .the .bloodstream.
ANS: . A
Drugs .given .by .the .parenteral .route .bypass .the .first-pass .effect, .but .they .still .must .be .absorbed .into .c
.can .exert .their .effects. .Enteral .drugs .(drugs .taken .orally), .not .parenteral .drugs, .decrease .blood .flow
.altered .by .the .presence .of .food .in .the .stomach. .Parenteral .drugs .must .be .absorbed .into .cells .and .tis
.before .they .can .exert .their .effects; .they .do .not .exert .their .effects .while .circulating .in .the .bloodstrea
DIF: Cognitive .Level: .Analysis
4. A .drug‘s .half-life .is .best .defined .as
a. The .time .it .takes .for .the .drug .to .elicit .half .its .therapeutic .response.
b. The .time .it .takes .one-half .of .the .original .amount .of .a .drug .to .reach .the
.target .cells.
c. The .time .it .takes .one-half .of .the .original .amount .of .a .drug .to .be .removed .from
.the .body.
d. The .time .it .takes .one-half .of .the .original .amount .of .a .drug .to .be .absorbed .into
.the .circulation.
ANS: . C
A .drug‘s .half-life .is .the .time .it .takes .for .one-half .of .the .original .amount .of .a .drug .to .be .removed .fro
lOMoARcPSD| 13728229
, lOMoARcPSD| 13728229
Chapter .01: .Nursing .Practice .in .Canada .and .Drug .Therapy
Sealock: .Lilley’s .Pharmacology .for .Canadian .Health .Care .Practice, .4th .Edition
MULTIPLE .CHOICE
1. Which .is .a .judgement .about .a .particular .patient‘s .potential .need .or .problem?
a. A .goal
b. An .assessment
c. Subjective .data
d. A .nursing .diagnosis
ANS: . D
Nursing .diagnosis .is .the .phase .of .the .nursing .process .during .which .a .clinical .judgement .is .made .abo
.to .heath .conditions .and .life .processes .or .vulnerability .for .that .response.
DIF: Cognitive .Level: .Knowledge
2. The .patient .is .to .receive .oral .furosemide .(Lasix) .every .day; .however, .because .the .patient .is .unable .t
.take .medication .orally, .as .ordered. .The .nurse .needs .to .contact .the .physician. .What .type .of .problem
a. A .―right .time‖ .problem
b. A .―right .dose‖ .problem
c. A .―right .route‖ .problem
d. A .―right .medication‖ .problem
ANS: . C
This .is .a .―right .route‖ .problem: .the .nurse .cannot .assume .the .route .and .must .clarify .the .route .with
.―right .time‖ .problem .because .the .ordered .frequency .has .not .changed. .This .is .not .a .―right .dose‖ .p
.not .related .to .an .inability .to .swallow. .This .is .not .a .―right .medication‖ .problem .because .the .m
.change, .just .the .route.
DIF: Cognitive .Level: .Application
3. The .nurse .has .been .monitoring .the .patient‘s .progress .on .his .new .drug .regimen .since .the .first .dose .an
.signs .of .possible .adverse .effects. .What .nursing .process .phase .is .the .nurse .practising?
a. Planning
b. Evaluation
c. Implementation
d. Nursing .diagnosis
ANS: . B
Monitoring .the .patient‘s .progress .is .part .of .the .evaluation .phase. .Planning, .implementation, .and .nurs
.illustrated .by .this .example.
DIF: Cognitive .Level: .Application
4. The .nurse .is .caring .for .a .patient .who .has .been .newly .diagnosed .with .type .1 .diabetes .mellitus. .Which
.illustrates .an .outcome .criterion .for .this .patient?
a. The .patient .will .follow .instructions.
b. The .patient .will .not .experience .complications.
c. The .patient .adheres .to .the .new .insulin .treatment .regimen.
d. The .patient .demonstrates .safe .insulin .self-administration .technique.
ANS: . D
Having .the .patient .demonstrate .safe .insulin .self-administration .technique .is .a .specific .and .measurabl
.Following .instructions .and .avoiding .complications .are .not .specific .criteria. .Adherence .to .the .new .in
.not .objective .and .would .be .difficult .to .measure.
DIF: Cognitive .Level: .Application
, lOMoARcPSD| 13728229
6. The .nurse .is .working .during .a .very .busy .night .shift, .and .the .health .care .provider .has .just .given .the .n
.over .the .telephone, .but .the .nurse .does .not .recall .the .route. .What .is .the .best .way .for .the .nurse .to .av
a. Recopy .the .order .neatly .on .the .order .sheet, .with .the .most .common .route .indicated
b. Consult .with .the .pharmacist .for .clarification .about .the .most .common .route
c. Call .the .health .care .provider .to .clarify .the .route .of .administration
d. Withhold .the .drug .until .the .health .care .provider .visits .the .patient
ANS: . C
If .a .medication .order .does .not .include .the .route, .the .nurse .must .ask .the .health .care .provider .to .clarif
.administration.
DIF: Cognitive .Level: .Application .| .Cognitive .Level: .Analysis
7. Which .constitutes .the .traditional .Five .Rights .of .medication .administration?
a. Right .drug, .right .route, .right .dose, .right .time, .and .right .patient
b. Right .drug, .the .right .effect, .the .right .route, .the .right .time, .and .the .right .patient
c. Right .patient, .right .strength, .right .diagnosis, .right .drug, .and .right .route
d. Right .patient, .right .diagnosis, .right .drug, .right .route, .and .right .time
ANS: . A
The .traditional .Five .Rights .of .medication .administration .were .considered .to .be .Right .drug, .Right .rou
.Right .patient. .Right .effect, .right .strength, .and .right .diagnosis .are .not .part .of .the .traditional .Five .Rig
DIF: Cognitive .Level: .Comprehension
8. What .correctly .describes .the .nursing .process?
a. Diagnosing, .planning, .assessing, .implementing, .and .finally .evaluating
b. Assessing, .then .diagnosing, .implementing, .and .ending .with .evaluating
c. A .linear .direction .that .begins .with .assessing .and .continues .through
.diagnosing, .planning, .and .finally .implementing
d. An .ongoing .process .that .begins .with .assessing .and .continues .with
.diagnosing, .planning, .implementing, .and .evaluating
ANS: . D
The .nursing .process .is .an .ongoing, .flexible, .adaptable, .and .adjustable .five-step .process .that .begins .w
.through .diagnosing, .planning, .implementing, .and .finally .evaluating, .which .may .then .lead .back .to .an
DIF: Cognitive .Level: .Application
9. When .the .nurse .is .considering .the .timing .of .a .drug .dose, .which .is .most .important .to .assess?
a. The .patient‘s .identification
b. The .patient‘s .weight
c. The .patient‘s .last .meal
d. Any .drug .or .food .allergies
ANS: . C
The .pharmacokinetic .and .pharmacodynamic .properties .of .the .drug .need .to .be .assessed .with .regard .to
.compatibility .issues. .The .patient‘s .identification, .weight, .and .drug .or .food .allergies .are .not .affected
DIF: Cognitive .Level: .Application
10. The .nurse .is .writing .nursing .diagnoses .for .a .plan .of .care. .Which .reflects .the .correct .format .for .her .n
a. Anxiety
b. Anxiety .related .to .new .drug .therapy
c. Anxiety .related .to .anxious .feelings .about .drug .therapy, .as .evidenced
.by .statements .such .as .―I‘m .upset .about .having .to .give .myself .shots‖
d. Anxiety .related .to .new .drug .therapy, .as .evidenced .by .statements .such .as
.―I‘m .upset .about .having .to .give .myself .shots‖
ANS: . D
Formulation .of .nursing .diagnoses .is .usually .a .three-step .process. .The .only .complete .answer .is .―Anx
, lOMoARcPSD| 13728229
Chapter .02: .Pharmacological .Principles
Sealock: .Lilley’s .Pharmacology .for .Canadian .Health .Care .Practice, .4th .Edition
MULTIPLE .CHOICE
1. A .patient .is .receiving .two .different .drugs, .which, .at .their .current .dose .forms .and .dosages, .are .both .a
.circulation .in .identical .amounts. .Which .term .best .denotes .that .the .drugs .have .the .same .absorption .r
a. Equivalent
b. Synergistic
c. Compatible
d. Bioequivalent
ANS: . D
Two .drugs .absorbed .into .the .circulation .at .the .same .amount .(in .specific .dosage .forms) .have .the .sam
.are .bioequivalent. .―Equivalent‖ .is .incorrect .because .the .term .―bioavailability‖ .is .used .to .express .the
.―Synergistic‖ .is .incorrect .because .this .term .refers .to .two .drugs .given .together .whose .resulting .effec
.the .effects .of .each .drug .given .alone. .―Compatible‖ .is .incorrect .because .this .term .is .a .general .term .u
.substances .do .not .have .a .chemical .reaction .when .mixed .(or .given, .in .the .case .of .drugs) .together.
DIF: Cognitive .Level: .Comprehension
2. A .patient .is .receiving .medication .via .intravenous .injection. .Which .information .should .the .nurse .prov
a. The .medication .will .cause .fewer .adverse .effects .when .given .intravenously.
b. The .medication .will .be .absorbed .slowly .into .the .tissues .over .time.
c. The .medication‘s .action .will .begin .faster .when .given .intravenously.
d. Most .of .the .drug .is .inactivated .by .the .liver .before .it .reaches .the .target .area.
ANS: . C
Intravenous .injections .are .the .fastest .route .of .absorption. .The .intravenous .route .does .not .affect .the .n
.the .intravenous .route .is .not .a .slow .route .of .absorption, .and .the .intravenous .route .does .not .cause .ina
.the .liver .before .it .reaches .the .target .area.
DIF: Cognitive .Level: .Comprehension
3. Which .is .true .regarding .parenteral .drugs?
a. They .bypass .the .first-pass .effect.
b. They .decrease .blood .flow .to .the .stomach.
c. They .are .altered .by .the .presence .of .food .in .the .stomach.
d. They .exert .their .effects .while .circulating .in .the .bloodstream.
ANS: . A
Drugs .given .by .the .parenteral .route .bypass .the .first-pass .effect, .but .they .still .must .be .absorbed .into .c
.can .exert .their .effects. .Enteral .drugs .(drugs .taken .orally), .not .parenteral .drugs, .decrease .blood .flow
.altered .by .the .presence .of .food .in .the .stomach. .Parenteral .drugs .must .be .absorbed .into .cells .and .tis
.before .they .can .exert .their .effects; .they .do .not .exert .their .effects .while .circulating .in .the .bloodstrea
DIF: Cognitive .Level: .Analysis
4. A .drug‘s .half-life .is .best .defined .as
a. The .time .it .takes .for .the .drug .to .elicit .half .its .therapeutic .response.
b. The .time .it .takes .one-half .of .the .original .amount .of .a .drug .to .reach .the
.target .cells.
c. The .time .it .takes .one-half .of .the .original .amount .of .a .drug .to .be .removed .from
.the .body.
d. The .time .it .takes .one-half .of .the .original .amount .of .a .drug .to .be .absorbed .into
.the .circulation.
ANS: . C
A .drug‘s .half-life .is .the .time .it .takes .for .one-half .of .the .original .amount .of .a .drug .to .be .removed .fro
